Last update 08 May 2025

Vudalimab

Overview

Basic Info

Drug Type
Bispecific antibody
Synonyms
+ [2]
Action
inhibitors, stimulants
Mechanism
CTLA4 inhibitors(Cytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors), PD-1 inhibitors(Programmed cell death protein 1 inhibitors), Immunostimulants
Originator Organization
Active Organization
Inactive Organization
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Endometrial CarcinomaPhase 2
United States
21 Jul 2022
Clear Cell AdenocarcinomaPhase 2
United States
21 Jul 2022
Metastatic Cervical CarcinomaPhase 2
United States
21 Jul 2022
Platinum-Resistant Ovarian CarcinomaPhase 2
United States
21 Jul 2022
Recurrent ovarian cancerPhase 2
United States
21 Jul 2022
Refractory Endometrial AdenocarcinomaPhase 2
United States
21 Jul 2022
Advanced biliary tract cancerPhase 2
United States
11 Apr 2022
Metastatic castration-resistant prostate cancerPhase 2
United States
22 Oct 2021
Castration-Resistant Prostatic CancerPhase 2--
Metastatic Thyroid Gland CarcinomaDiscovery
United States
21 Jul 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
34
(rxsvwffgmd) = 24% [elevations of transaminases 3 (9%), rash 2 (6%), lipase and amylase 1 (3%, without clinical symptoms or radiographic evidence of pancreatitis), lipase (alone) 1 (3%), pruritus 1 (3%), hyperglycaemia 1 (3%), arthritis 1 (3%) and colitis 1 (3%), all reversible] obcewcjsqm (nmvjvjgdwn )
Positive
29 May 2020
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free